STOCK TITAN

Flexion Therapeutics to Present at the 42nd Annual Raymond James Virtual Institutional Investors Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Flexion Therapeutics (Nasdaq:FLXN) announced that Dr. Michael Clayman, President and CEO, will participate in an analyst-led fireside chat at the 42nd Annual Raymond James Institutional Investors Conference. The virtual event is set for 12:30 p.m. ET on March 1, 2021. Interested parties can access the live webcast through the Flexion Therapeutics website, which focuses on innovative local therapies for musculoskeletal conditions, particularly osteoarthritis. Key company values include focus, ingenuity, tenacity, transparency, and fun.

Positive
  • None.
Negative
  • None.

BURLINGTON, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the 42nd Annual Raymond James Institutional Investors Conference. The virtual fireside chat is scheduled to begin at 12:30 p.m. ET on Monday, March 1, 2021.

To access the live webcast of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com.

About Flexion Therapeutics
Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun. Please visit flexiontherapeutics.com.

Contact:

Scott Young
Vice President, Corporate Communications & Investor Relations
Flexion Therapeutics, Inc.
T: 781-305-7194
syoung@flexiontherapeutics.com


FAQ

When is Flexion Therapeutics' fireside chat at the Raymond James Institutional Investors Conference?

Flexion Therapeutics' fireside chat is scheduled for 12:30 p.m. ET on March 1, 2021.

Who will represent Flexion Therapeutics at the conference?

Dr. Michael Clayman, President and CEO, will represent Flexion Therapeutics.

How can I access the Flexion Therapeutics conference webcast?

The webcast can be accessed via the Flexion Therapeutics website.

What is the focus of Flexion Therapeutics?

Flexion Therapeutics focuses on developing novel therapies for musculoskeletal conditions, starting with osteoarthritis.

What are the core values of Flexion Therapeutics?

Flexion Therapeutics values focus, ingenuity, tenacity, transparency, and fun.

FLXN

NASDAQ:FLXN

FLXN Rankings

FLXN Latest News

FLXN Stock Data

47.41M
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States
Burlington